ReviewPublic health reviews2018
Screening and treatment of hypertension in older adults: less is more?
Review in Public health reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.
- Development of a high-performing, cost-effective and inclusive Afrocentric predictive model for stroke: a meta-analysis approach.BMC neurology · 2025Pooled it
- Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysis.Journal of hypertension · 2022Pooled it
- Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases.Age and ageing · 2022Pooled it
- Utilization Trends and Outcomes of Alteplase in Acute Cerebral Ischemia among Patients with Hypertension or Diabetes: A Tertiary Care Experience from Southern Punjab.Cardiovascular & hematological disorders drug targets · 2025Observational
- Prevalence and predictors of frailty among community-dwelling older adults with hypertension in China.Revista da Associacao Medica Brasileira (1992) · 2025Article
- Optimal Systolic Blood Pressure for the Prevention of All-Cause and Cardiovascular Disease Mortality in Older Adults With Hypertension: Nationwide Population-Based Cohort Study.JMIR public health and surveillance · 2024Article
- Higher Hospital Frailty Risk Score Is an Independent Predictor of In-Hospital Mortality in Hospitalized Older Adults with Obstructive Sleep Apnea.Geriatrics (Basel, Switzerland) · 2022Article
- How blood pressure predicts frailty transitions in older adults in a population-based cohort study: a multi-state transition model.International journal of epidemiology · 2022Article
- Physical decline and cognitive impairment in frail hypertensive elders during COVID-19.European journal of internal medicine · 2022Article
- Effects of Acute Interval Exercise on Arterial Stiffness and Cardiovascular Autonomic Regulatory Responses: A Narrative Review of Potential Impacts of Aging.Frontiers in cardiovascular medicine · 2022Review
- Absolute Cardiovascular Disease Risk Assessed in Old Age Predicts Disability and Mortality: A Retrospective Cohort Study of Community-Dwelling Older Adults.Journal of the American Heart Association · 2021Article
- Adherence to Treatment and Level of Satisfaction Among Saudi Hypertensive Patients: A Multi-City Study.Cureus · 2021Article
- Elderly Patients in a Large Nephrology Unit: Who Are Our Old, Old-Old and Oldest-Old Patients?Journal of clinical medicine · 2021Article
- Blood pressure control and complex health conditions in older adults: impact of recent hypertension management guidelines.Journal of human hypertension · 2021Article
- Unique hemoglobin dynamics in female Tibetan highlanders.Tropical medicine and health · 2021Article
- Time course of tolerance to adverse effects associated with the ingestion of a moderate dose of caffeine.European journal of nutrition · 2020Article
- [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.]Revista espanola de salud publica · 2020Review
- Credibility of self-reported health parameters in elderly population.Primary health care research & development · 2020Article
- Blood pressure in relation to frailty in older adults: A population-based study.Journal of clinical hypertension (Greenwich, Conn.) · 2019Article
- Hypertension and Stroke: Update on Treatment.European cardiology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Screening and treatment of hypertension is a cornerstone of cardiovascular disease (CVD) prevention. Hypertension causes a large proportion of cases of stroke, coronary heart disease, heart failure, and associated disability and is highly prevalent especially among older adults. On the one hand, there is robust evidence that screening and treatment of hypertension prevents CVD and decreases mortality in the middle-aged population. On the other hand, among older adults, observational studies have shown either positive, negative, or no correlation between blood pressure (BP) and cardiovascular outcomes. Furthermore, there is a lack of high quality evidence for a favorable harm-benefit balance of antihypertensive treatment among older adults, especially among the oldest-old (i.e., above the age of 80 years), because very few trials have been conducted in this population. The optimal target BP may be higher among older treated hypertensive patients than among middle-aged. In addition, among frail or multimorbid older individuals, a relatively low BP may be associated with worse outcomes, and antihypertensive treatment may cause more harm than benefit. To guide hypertension screening and treatment recommendations among older patients, additional studies are needed to determine the most efficient screening strategies, to evaluate the effect of lowering BP on CVD risk and on mortality, to determine the optimal target BP, and to better understand the relationship between BP, frailty, multimorbidity, and health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.